Transcription Factor EB Is Selectively Reduced in the Nuclear Fractions of Alzheimer’s and Amyotrophic Lateral Sclerosis Brains

Table 1

Demographics of normal control subjects and Alzheimer’s disease patients obtained from Harvard Brain Tissue Resource Center, used in this study.

Numbers	Diagnosis	Age (y)	Sex	PMI (h)	Tissue
1	Normal control	58	F	26.60	Hippocampus
2	Normal control	77	F	28.00	Hippocampus
3	Normal control	82	M	24.08	Hippocampus
4	Normal control	86	F	29.18	Hippocampus
5	Normal control	82	F	24.42	Hippocampus
6	AD/Braak 2	72	M	6.83	Hippocampus
7	AD/Braak 2	74	M	25.00	Hippocampus
8	AD/Braak 2	81	F	6.33	Hippocampus
9	AD/Braak 3	87	F	22.32	Hippocampus
10	AD/Braak 3	97	F	20.66	Hippocampus
11	AD/Braak 3	77	M	30.83	Hippocampus
12	AD/Braak 3	80	M	23.17	Hippocampus
13	AD/Braak 3	88	F	17.67	Hippocampus
14	AD/Braak 3	89	M	27.17	Hippocampus
15	AD/Braak 4	90	M	24.00	Hippocampus
16	AD/Braak 4	84	F	22.08	Hippocampus
17	AD/Braak 4	83	F	15.63	Hippocampus
18	AD/Braak 4	81	F	22.00	Hippocampus
19	AD/Braak 4	93	F	21.50	Hippocampus
20	AD/Braak 5	83	M	15.90	Hippocampus
21	AD/Braak 5	73	F	29.92	Hippocampus
22	AD/Braak 5	83	M	8.67	Hippocampus
23	AD/Braak 5	80	M	27.50	Hippocampus
24	AD/Braak 5	80	F	9.42	Hippocampus
25	AD/Braak 6	71	M	16.62	Hippocampus
26	AD/Braak 6	84	M	6.66	Hippocampus
27	AD/Braak 6	95	M	15.00	Hippocampus
28	AD/Braak 6	72	M	16.08	Hippocampus

AD: Alzheimer’s disease; M: male; F: female; PMI: postmortem interval in hours.